Concepedia

John Ridley

JR

11

Publications

518

Citations

11

H-Index

2003

Active since

Affiliations

University of Bristol(Current)

Pfizer (United Kingdom)

John Ridley is an author at University of Bristol specializing in medicine, pharmacology, and molecular pharmacology.

Top concepts

Publications per year

2003–2008

11

Publications

11

High affinity HERG K+ channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656

John Ridley, James T. Milnes, Harry J. Witchel et al. · Biochemical and Biophysical Research Communications · 2004 · 76 citations

, , +7

Preferential closed channel blockade of HERG potassium currents by chemically synthesised BeKm‐1 scorpion toxin

James T. Milnes, Christopher E. Dempsey, John Ridley et al. · FEBS Letters · 2003 · 72 citations · Full text

Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin

Rona S. Duncan, Mark J. McPate, John Ridley et al. · Biochemical Pharmacology · 2007 · 57 citations · Full text

Lidoflazine is a high affinity blocker of the HERG K+channel

John Ridley · Journal of Molecular and Cellular Cardiology · 2004 · 55 citations

, , +8

Inhibition of HERG K<sup>+</sup> Current and Prolongation of the Guinea‐Pig Ventricular Action Potential by 4‐Aminopyridine

John Ridley, James T. Milnes, Y. H. Zhang et al. · The Journal of Physiology · 2003 · 53 citations · Full text

, , +16

Rows per page

1–5 of 11